산화 스트레스 어세이 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)
Oxidative Stress Assays Market (Product Type, Flow Cytometry, High-content Screening, Label-free Detection, Microscopy, and Chromatography) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1552956
리서치사:Transparency Market Research
발행일:2024년 07월
페이지 정보:영문 145 Pages
라이선스 & 가격 (부가세 별도)
한글목차
산화 스트레스 어세이 시장 - 조사 범위
TMR의 조사 보고서 "세계 산화 스트레스 어세이 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사합니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 산화 스트레스 어세이 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 산화 스트레스 어세이 시장의 복합 연간 성장률(CAGR %)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 산화 스트레스 어세이 시장을 이해하고자 했습니다.
시장 스냅샷
2023년 시장 규모
10억 달러
2034년 시장 규모
28억 달러
CAGR
9.4%
이 보고서는 세계 산화 스트레스 어세이 시장의 경쟁 환경을 조사하고 있습니다. 세계 산화 스트레스 어세이 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되어 있습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등 세계 산화 스트레스 어세이 시장 기업의 속성은 이 보고서에서 다루고 있습니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 시장 분석과 예측 c
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19에 의한 산업에 대한 영향
제6장 세계의 시장 분석과 예측 : 제품 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 제품 유형별, 2020-2034년
소모품
키트·시약
기기
서비스
시장 매력 : 제품 유형별
제7장 세계의 시장 분석과 예측 : 테스트 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 테스트 유형별, 2020-2034년
항산화능 어세이
아스코르브산 어세이
글루타티온 어세이
세포 기반 외인성항산화물질 어세이
간접 어세이
지질 기반 어세이
핵산 기반 어세이
단백질 기반 어세이
효소 기반 어세이
활성 산소종 기반 어세이
시장 매력 : 테스트 유형별
제8장 세계의 시장 분석과 예측 : 기술별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 기술별, 2020-2034년
효소면역측정법(ELISA)
유세포 분석
HCS(High Content Screening)(HCS)
무표지 검출
현미경 검사
크로마토그래피
시장 매력 : 기술별
제9장 세계의 시장 분석과 예측 : 질환 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 질환 유형별, 2020-2034년
심혈관질환
당뇨병
암
호흡기질환
기타(희귀질환 등)
시장 매력 : 질병 유형별
제10장 세계의 시장 분석과 예측 : 최종사용자별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 최종사용자별, 2020-2034년
임상 검사실
CRO
바이오의약품 기업
학술·연구기관
시장 매력 : 최종사용자별
제11장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 : 지역별
제12장 북미의 시장 분석과 예측
제13장 유럽의 시장 분석과 예측
제14장 아시아태평양의 시장 분석과 예측
제15장 라틴아메리카의 시장 분석과 예측
제16장 중동 및 아프리카의 시장 분석과 예측
제17장 경쟁 상황
시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023)
기업 개요
Abcam Ltd.
AMSBIO
BioVision, an Abcam Company
Cell Biolabs Inc
Enzo Life Sciences
Merck KGaA
ImmunoChemistry Technologies, LLC
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific
ksm
영문 목차
영문목차
Oxidative Stress Assays Market - Scope of Report
TMR's report on the global oxidative stress assays market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oxidative stress assays market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oxidative stress assays market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oxidative stress assays market.
Market Snapshot
Market Value in 2023
US$ 1 Bn
Market Value in 2034
US$ 2.8 Bn
CAGR
9.4%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oxidative stress assays market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oxidative stress assays market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oxidative stress assays market.
The report delves into the competitive landscape of the global oxidative stress assays market. Key players operating in the global oxidative stress assays market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oxidative stress assays market profiled in this report.
Key Questions Answered in Global oxidative stress assays Market Report:
What is the sales/revenue generated by oxidative stress assays across all regions during the forecast period?
What are the opportunities in the global oxidative stress assays market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Oxidative Stress Assays Market - Research Objectives and Research Approach
The comprehensive report on the global oxidative stress assays market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global oxidative stress assays market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oxidative stress assays market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oxidative Stress Assays Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oxidative Stress Assays Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Oxidative Stress Assays Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Consumables
6.3.2. Kits and Reagents
6.3.3. Instruments
6.3.4. Services
6.4. Market Attractiveness, by Product Type
7. Global Oxidative Stress Assays Market Analysis and Forecast, by Test Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Antioxidant Capacity Assays
7.3.2. Ascorbic Acid Assays
7.3.3. Glutathione Assays
7.3.4. Cell-based Exogenous Antioxidant Assays
7.3.5. Indirect Assays
7.3.6. Lipid-based Assays
7.3.7. Nucleic Acid-based Assays
7.3.8. Protein-based Assays
7.3.9. Enzyme-based Assays
7.3.10. Reactive Oxygen Species-based Assays
7.4. Market Attractiveness, by Test Type
8. Global Oxidative Stress Assays Market Analysis and Forecast, By Technology
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Technology, 2020-2034
8.3.1. Enzyme-linked Immunosorbent Assay (ELISA)
8.3.2. Flow Cytometry
8.3.3. High-content Screening (HCS)
8.3.4. Label-free Detection
8.3.5. Microscopy
8.3.6. Chromatography
8.4. Market Attractiveness, By Technology
9. Global Oxidative Stress Assays Market Analysis and Forecast, by Disease Type
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Disease Type, 2020-2034
9.3.1. Cardiovascular Disease
9.3.2. Diabetes
9.3.3. Cancer
9.3.4. Respiratory Diseases
9.3.5. Others (Rare Disorders, etc.)
9.4. Market Attractiveness, by Disease Type
10. Global Oxidative Stress Assays Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2034
10.3.1. Clinical Laboratories
10.3.2. Contract Research Organizations
10.3.3. Biopharmaceutical Companies
10.3.4. Academic & Research Organizations
10.4. Market Attractiveness, by End-user
11. Global Oxidative Stress Assays Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2034
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Oxidative Stress Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Consumables
12.2.2. Kits and Reagents
12.2.3. Instruments
12.2.4. Services
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Antioxidant Capacity Assays
12.4.2. Ascorbic Acid Assays
12.4.3. Glutathione Assays
12.4.4. Cell-based Exogenous Antioxidant Assays
12.4.5. Indirect Assays
12.4.6. Lipid-based Assays
12.4.7. Nucleic Acid-based Assays
12.4.8. Protein-based Assays
12.4.9. Enzyme-based Assays
12.4.10. Reactive Oxygen Species-based Assays
12.5. Market Attractiveness, by Test Type
12.6. Market Value Forecast, By Technology, 2020-2034
12.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
12.6.2. Flow Cytometry
12.6.3. High-content Screening (HCS)
12.6.4. Label-free Detection
12.6.5. Microscopy
12.6.6. Chromatography
12.7. Market Attractiveness, By Technology
12.8. Market Value Forecast, by Disease Type, 2020-2034
12.8.1. Cardiovascular Disease
12.8.2. Diabetes
12.8.3. Cancer
12.8.4. Respiratory Diseases
12.8.5. Others (Rare Disorders, etc.)
12.9. Market Attractiveness, by Disease Type
12.10. Market Value Forecast, by End-user, 2020-2034
12.10.1. Clinical Laboratories
12.10.2. Contract Research Organizations
12.10.3. Biopharmaceutical Companies
12.10.4. Academic & Research Organizations
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Product Type
12.13.2. By Test Type
12.13.3. By Technology
12.13.4. By Disease Type
12.13.5. By End-user
12.13.6. By Country
13. Europe Oxidative Stress Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Consumables
13.2.2. Kits and Reagents
13.2.3. Instruments
13.2.4. Services
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Antioxidant Capacity Assays
13.4.2. Ascorbic Acid Assays
13.4.3. Glutathione Assays
13.4.4. Cell-based Exogenous Antioxidant Assays
13.4.5. Indirect Assays
13.4.6. Lipid-based Assays
13.4.7. Nucleic Acid-based Assays
13.4.8. Protein-based Assays
13.4.9. Enzyme-based Assays
13.4.10. Reactive Oxygen Species-based Assays
13.5. Market Attractiveness, by Test Type
13.6. Market Value Forecast, By Technology, 2020-2034
13.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
13.6.2. Flow Cytometry
13.6.3. High-content Screening (HCS)
13.6.4. Label-free Detection
13.6.5. Microscopy
13.6.6. Chromatography
13.7. Market Attractiveness, By Technology
13.8. Market Value Forecast, by Disease Type, 2020-2034
13.8.1. Cardiovascular Disease
13.8.2. Diabetes
13.8.3. Cancer
13.8.4. Respiratory Diseases
13.8.5. Others (Rare Disorders, etc.)
13.9. Market Attractiveness, by Disease Type
13.10. Market Value Forecast, by End-user, 2020-2034
13.10.1. Clinical Laboratories
13.10.2. Contract Research Organizations
13.10.3. Biopharmaceutical Companies
13.10.4. Academic & Research Organizations
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Product Type
13.13.2. By Test Type
13.13.3. By Technology
13.13.4. By Disease Type
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Oxidative Stress Assays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Consumables
14.2.2. Kits and Reagents
14.2.3. Instruments
14.2.4. Services
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Antioxidant Capacity Assays
14.4.2. Ascorbic Acid Assays
14.4.3. Glutathione Assays
14.4.4. Cell-based Exogenous Antioxidant Assays
14.4.5. Indirect Assays
14.4.6. Lipid-based Assays
14.4.7. Nucleic Acid-based Assays
14.4.8. Protein-based Assays
14.4.9. Enzyme-based Assays
14.4.10. Reactive Oxygen Species-based Assays
14.5. Market Attractiveness, by Test Type
14.6. Market Value Forecast, By Technology, 2020-2034
14.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
14.6.2. Flow Cytometry
14.6.3. High-content Screening (HCS)
14.6.4. Label-free Detection
14.6.5. Microscopy
14.6.6. Chromatography
14.7. Market Attractiveness, By Technology
14.8. Market Value Forecast, by Disease Type, 2020-2034
14.8.1. Cardiovascular Disease
14.8.2. Diabetes
14.8.3. Cancer
14.8.4. Respiratory Diseases
14.8.5. Others (Rare Disorders, etc.)
14.9. Market Attractiveness, by Disease Type
14.10. Market Value Forecast, by End-user, 2020-2034
14.10.1. Clinical Laboratories
14.10.2. Contract Research Organizations
14.10.3. Biopharmaceutical Companies
14.10.4. Academic & Research Organizations
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Product Type
14.13.2. By Test Type
14.13.3. By Technology
14.13.4. By Disease Type
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Oxidative Stress Assays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Consumables
15.2.2. Kits and Reagents
15.2.3. Instruments
15.2.4. Services
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Test Type, 2020-2034
15.4.1. Antioxidant Capacity Assays
15.4.2. Ascorbic Acid Assays
15.4.3. Glutathione Assays
15.4.4. Cell-based Exogenous Antioxidant Assays
15.4.5. Indirect Assays
15.4.6. Lipid-based Assays
15.4.7. Nucleic Acid-based Assays
15.4.8. Protein-based Assays
15.4.9. Enzyme-based Assays
15.4.10. Reactive Oxygen Species-based Assays
15.5. Market Attractiveness, by Test Type
15.6. Market Value Forecast, By Technology, 2020-2034
15.6.1. Enzyme-linked Immunosorbent Assay (ELISA)
15.6.2. Flow Cytometry
15.6.3. High-content Screening (HCS)
15.6.4. Label-free Detection
15.6.5. Microscopy
15.6.6. Chromatography
15.7. Market Attractiveness, By Technology
15.8. Market Value Forecast, by Disease Type, 2020-2034
15.8.1. Cardiovascular Disease
15.8.2. Diabetes
15.8.3. Cancer
15.8.4. Respiratory Diseases
15.8.5. Others (Rare Disorders, etc.)
15.9. Market Attractiveness, by Disease Type
15.10. Market Value Forecast, by End-user, 2020-2034
15.10.1. Clinical Laboratories
15.10.2. Contract Research Organizations
15.10.3. Biopharmaceutical Companies
15.10.4. Academic & Research Organizations
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Product Type
15.13.2. By Test Type
15.13.3. By Technology
15.13.4. By Disease Type
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Oxidative Stress Assays Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product Type, 2020-2034
16.2.1. Consumables
16.2.2. Kits and Reagents
16.2.3. Instruments
16.2.4. Services
16.3. Market Attractiveness, by Product Type
16.4. Market Value Forecast, by Test Type, 2020-2034
16.4.1. Antioxidant Capacity Assays
16.4.2. Ascorbic Acid Assays
16.4.3. Glutathione Assays
16.4.4. Cell-based Exogenous Antioxidant Assays
16.4.5. Indirect Assays
16.4.6. Lipid-based Assays
16.4.7. Nucleic Acid-based Assays
16.4.8. Protein-based Assays
16.4.9. Enzyme-based Assays
16.4.10. Reactive Oxygen Species-based Assays
16.5. Market Attractiveness, by Test Type
16.6. Market Value Forecast, By Technology, 2020-2034
16.6.1. Cardiovascular Disease
16.6.2. Diabetes
16.6.3. Cancer
16.6.4. Respiratory Diseases
16.6.5. Others (Rare Disorders, etc.)
16.6.6. Market Attractiveness, By Technology
16.7. Market Value Forecast, by Disease Type, 2020-2034
16.7.1. Companion Animal
16.7.2. Livestock Animal
16.8. Market Attractiveness, by Disease Type
16.9. Market Value Forecast, by End-user, 2020-2034
16.9.1. Clinical Laboratories
16.9.2. Contract Research Organizations
16.9.3. Biopharmaceutical Companies
16.9.4. Academic & Research Organizations
16.10. Market Attractiveness, by End-user
16.11. Market Value Forecast, by Country/Sub-region, 2020-2034
16.11.1. GCC Countries
16.11.2. South Africa
16.11.3. Rest of Middle East & Africa
16.12. Market Attractiveness Analysis
16.12.1. By Product Type
16.12.2. By Test Type
16.12.3. By Technology
16.12.4. By Disease Type
16.12.5. By End-user
16.12.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. Abcam Ltd.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. AMSBIO
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. BioVision, an Abcam Company
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Cell Biolabs Inc
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Enzo Life Sciences
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Merck KGaA
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. ImmunoChemistry Technologies, LLC
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Promega Corporation
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Qiagen N.V.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Thermo Fisher Scientific
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
